Menu
← Oncology Approval Tracker
FDA DECISION ·
Methotrexate injection
methotrexate · Accord Healthcare
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Intravenous methotrexate for combination regimens in adults and children with acute lymphoblastic leukemia, Burkitt lymphoma or osteosarcoma, and in adults with relapsed or refractory non-Hodgkin lymphoma.
LAMPGEN ANALYSIS
Why it matters
Added a new injectable presentation for established combination chemotherapy uses.
What research teams should watch
Verify the 100 mg/mL concentration, the intravenous route and protocol-specific supportive care.
PRIMARY RECORDS